Diarrhea News and Research

Latest Diarrhea News and Research

Clinical trial to test whether fecal transplantation is effective in treating relapsing C. difficile

For patients with Clostridium difficile (C. difficile), a persistent and potentially deadly bacterial illness, severe diarrhea, abdominal pain, nausea and vomiting are an everyday event. This particularly virulent infection is prone to recurrence, even after multiple courses of expensive antibiotics, and treatment options are limited for patients who continually relapse or develop antibiotic resistance.

22 Aug 2012

FDA committee to review NPS’ Gattex NDA in October

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.

22 Aug 2012

Women in developing countries could play a major role in remedying sanitation and water crisis

People in ancient Rome 2,000 years ago had better access to clean water and sanitation that keeps disease-causing human excrement out of contact with people than many residents of the 21st century, a scientist said here today.

21 Aug 2012

Sierra Leone declares cholera outbreak a national emergency

"Sierra Leone has declared a cholera outbreak that has left 176 people dead since the start of the year a national humanitarian emergency, officials said Friday," AlertNet reports, adding, "Jonathan Abass Kamara, public relations officer for Sierra Leone's health ministry, said the outbreak was the worst in the West Africa country's history."

21 Aug 2012

Enzalutamide extends castration-resistant prostate cancer survival

Enzalutamide treatment significantly improves survival in men with castration-resistant prostate cancer, demonstrate phase III trial results published in TheNew England Journal of Medicine.

20 Aug 2012

Pennsylvania Department of Health reports four confirmed and six probable cases of H3N2v flu

The Pennsylvania Department of Health today reported four confirmed and six probable human cases of influenza due to a new strain of the flu known as H3N2v.

18 Aug 2012

Franchise clinics improve healthcare access for children in developing world

Franchise health clinics could substantially increase access to essential vaccinations and treatments among children living in low-income countries, regardless of their household income status, report researchers.

17 Aug 2012

Blog examines administration of zinc, rehydration salts to treat diarrhea in rural India

In this post in the PLoS "Speaking of Medicine" blog, guest blogger Oliver Sabot, executive vice president of the Clinton Health Access Initiative, "reflects on the challenge and opportunity of scaling-up access to effective treatment for diarrhea, the second largest cause of child mortality globally."

17 Aug 2012

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine.

16 Aug 2012

Continuous oral contraceptives provide earlier relief for women with dysmenorrhea

Taking oral contraceptives continuously, rather than as traditionally prescribed for each cycle, provides earlier relief for moderate to severe menstrual cramps -- dysmenorrhea -- according to researchers at Penn State College of Medicine.

16 Aug 2012

FDA extends PDUFA target action date for review of Santarus' UCERIS NDA

Santarus, Inc. today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for the review of the New Drug Application (NDA) for UCERIS (budesonide) tablets 9 mg for the induction of remission of mild to moderate active ulcerative colitis from October 16, 2012 to January 16, 2013.

14 Aug 2012

‘Low’ toxicity for phase I cancer trials

Advanced cancer patients participating in phase I clinical trials at the University of Texas MD Anderson Cancer Center experienced a low rate of toxicity, researchers say.

13 Aug 2012

FDA extends PDUFA action date for NPS Gattex NDA

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has received a communication from the U.S. Food and Drug Administration extending the Prescription Drug User Fee Act action date for its New Drug Application for Gattex (teduglutide) by three months to December 30, 2012.

13 Aug 2012

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.

12 Aug 2012

FDA approved drug to treat Ph- acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.

10 Aug 2012

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.

9 Aug 2012

New clinical trial to study how worm eggs may relieve symptoms of ulcerative colitis

A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.

8 Aug 2012

Communal violence in India forces up to 400,000 into overcrowded camps without sufficient food, water, medicine

"Hundreds of thousands of people sheltering in squalid, overcrowded camps in India's northeast desperately need food, water and medicines after fleeing some of the worst communal violence in a decade, officials and aid workers said on Monday," AlertNet reports.

8 Aug 2012

Orexigen Therapeutics reports net loss of $16.7 million for second quarter 2012

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.

7 Aug 2012

NYUCN professor to investigate efficacy of Acu/Moxa in managing irritable bowel syndrome

New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".

7 Aug 2012

Diarrhea News and Research

Latest Diarrhea News and Research

Clinical trial to test whether fecal transplantation is effective in treating relapsing C. difficile

FDA committee to review NPS’ Gattex NDA in October

Women in developing countries could play a major role in remedying sanitation and water crisis

Sierra Leone declares cholera outbreak a national emergency

Enzalutamide extends castration-resistant prostate cancer survival

Pennsylvania Department of Health reports four confirmed and six probable cases of H3N2v flu

Franchise clinics improve healthcare access for children in developing world

Blog examines administration of zinc, rehydration salts to treat diarrhea in rural India

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

Continuous oral contraceptives provide earlier relief for women with dysmenorrhea

FDA extends PDUFA target action date for review of Santarus' UCERIS NDA

‘Low’ toxicity for phase I cancer trials

FDA extends PDUFA action date for NPS Gattex NDA

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

FDA approved drug to treat Ph- acute lymphoblastic leukemia

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

New clinical trial to study how worm eggs may relieve symptoms of ulcerative colitis

Communal violence in India forces up to 400,000 into overcrowded camps without sufficient food, water, medicine

Orexigen Therapeutics reports net loss of $16.7 million for second quarter 2012

NYUCN professor to investigate efficacy of Acu/Moxa in managing irritable bowel syndrome

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Diarrhea News and Research

Latest Diarrhea News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in